Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interventions for Preventing Osteoporosis in Women on Heparin Therapy During Pregnancy Publisher



Abdollahi M1 ; Nikfar S2 ; Hosseinitabatabaei A3 ; Rezaie A4 ; Kellie FJ5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences, Faculty of Pharmacy, and Pharmaceutical Sciences Research Centre, Keshavarz Bulvd., Tehran, Tehran, 1417614411, Iran
  2. 2. Tehran University of Medical Sci., Faculty of Pharmacy, Food and Drug Laboratory Research Centre, Deputy for Food and Drug Affairs, Iranian Ministry of Health and Medical Education, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran, Iran
  3. 3. University of British Columbia, Department of Surgery, Burn and Wound Healing Research Lab, Jack Bell Research Centre, 2660 Oak St., Vancouver, V6H 3Z6, BC, Canada
  4. 4. Cedars-Sinai Medical Center, Department of Medicine, Los Angeles, 90048, CA, United States
  5. 5. The University of Liverpool, Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, Liverpool Women's NHS Foundation Trust, First Floor, Crown Street, Liverpool, L8 7SS, United Kingdom

Source: Cochrane Database of Systematic Reviews Published:2015


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To investigate the effectiveness and tolerability of various medications for management of osteoporosis in pregnant women undergoing long-term heparin therapy. © 2015 The Cochrane Collaboration.
Experts (# of related papers)
Other Related Docs
18. Water Intake and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021)
26. Prevalence of Preeclampsia and Eclampsia in Iran, Archives of Iranian Medicine (2016)